AGP Executive Report
Last update: 2 hours agoBladder Cancer Breakthrough: The EMA’s CHMP backed perioperative KEYTRUDA (pembrolizumab) plus PADCEV (enfortumab vedotin-ejfv) for resectable muscle-invasive bladder cancer, including a subcutaneous KEYTRUDA option; the European Commission now has the final say for EU, Iceland, Liechtenstein and Norway, expected in Q4 2026. Border Tech Friction: The EU allowed at least nine Schengen countries—including Switzerland—to pause full rollout of the Entry/Exit System (EES) until facial and fingerprint tech is ready, after queues and missed flights sparked fresh criticism. EU-Canada Partnership Push: Ursula von der Leyen invited Canada to become the EU’s first “associate member,” but details remain undefined; Mark Carney framed it as an “alliance” with possible links to tech, defence, AI, and even Erasmus+ talks. Space Research Pathway: Switzerland and Liechtenstein’s space hub is building a route from ground testing to ISS microgravity work with Starlab, plus new parabolic flight campaigns. Digital Commerce Rules: Google started removing product carousels from shopping search results across the EEA to comply with the Digital Markets Act, hitting retailer visibility hard. Banking App Upgrade: Switzerland’s CA next bank went live with Avaloq’s new mobile banking system, aiming to expand secure self-service on smartphones.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
